Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development. [electronic resource]
Producer: 20120402Description: e27518 p. digitalISSN:- 1932-6203
- Amino Acid Sequence
- Binding Sites
- Databases as Topic
- Drug Evaluation, Preclinical -- methods
- HIV Reverse Transcriptase -- antagonists & inhibitors
- Humans
- Ligands
- Models, Molecular
- Molecular Sequence Data
- Mutation -- genetics
- Proteomics -- methods
- Reproducibility of Results
- Reverse Transcriptase Inhibitors -- analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.